This is a distressed financing. The $400,000 raise addresses near-term liquidity but comes with punitive mandatory redemption at 125% of stated value ($500k total) over four months with potential conversion into stock at a price ($0.50) likely above the current market value of a sub-$4M market cap stock. Track whether the company can obtain shareholder approval to allow conversion, which would avoid cash redemption but massively dilute existing holders. Monitor cash burn and Nasdaq listing compliance.
Price Chart
Executive Summary
Avalon GloboCare Corp. raised $400,000 via a private placement of Series F Convertible Preferred Stock and common stock commitment shares to a single accredited investor. The deal includes mandatory redemption at 125% of stated value over four months and a conversion price of $0.50 per share, subject to shareholder approval. Additionally, the company issued options for 2,150,000 shares to officers, directors, and consultants, and issued 1,100,000 restricted common shares for services and a waiver, all of which significantly dilute existing common shareholders.
Key Financial Metrics
Key Facts
- Company raised $400,000 via sale of 400 shares of Series F Convertible Preferred Stock at $1,000 stated value and 200,000 commitment shares of common stock to investor Allen O. Cage Jr., closing July 2, 2026.
- Series F Preferred converts to common at $0.50/share, subject to shareholder approval and a 4.99% beneficial ownership limitation on the holder.
- Mandatory redemption of 25% of outstanding Series F Preferred on each of Oct 1, Nov 1, Dec 1, 2026, and Jan 1, 2027 at 125% of stated value ($1,250 per share in cash).
- On June 29, 2026, issued three-year options to purchase 1,150,000 shares to officers (Luisa Ingargiola 400k, Meng Li 400k, Brio/Sam Knipper 350k) at $0.2820 per share.
- On June 29, 2026, issued options to purchase 600,000 shares to non-employee directors at $0.2820 per share.
- On June 29, 2026, issued 150,000 restricted shares to a consultant for services.
- On June 29, 2026, issued options to purchase 400,000 shares to consultants at $0.2820 per share.
- On July 1, 2026, issued 200,000 common shares for a waiver.
- On July 2, 2026, issued 750,000 restricted shares to consultants for services.
- Total new option grants: 2,150,000 shares; total new restricted common shares issued: 1,100,000 shares.
- Market cap is approximately $4 million, making this a distressed micro-cap financing.
Financial Impact
Net cash infusion of $400,000 with significant dilution: up to 800,000 common shares upon full conversion of Series F ($0.50 strike) plus 2,150,000 in new options at $0.2820 plus 1,100,000 newly issued shares, for a total potential dilution of over 4 million shares against a $4M market cap company. Mandatory redemption obligations of up to $500,000 in cash by January 2027.
Risk Factors
- Dilution risk from conversion of Series F Preferred at $0.50/share and exercise of 2,150,000 options at $0.2820 per share.
- Liquidity risk: mandatory cash redemption of $500,000 over the next six months may strain a company with only $4M market cap.
- Nasdaq delisting risk: use of shares for services and waivers may signal difficulty in meeting continued listing standards.
- All securities issued are unregistered, limiting near-term resale and increasing overhang uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-075090 |
| Document: ea029696701ex10-1.htm | 0001213900-26-075090 |
| Document: ea0296967-8k_avalon.htm | 0001213900-26-075090 |
| Document: 0001213900-26-075090-index-headers.html | 0001213900-26-075090 |
| Document: 0001213900-26-075090-index.html | 0001213900-26-075090 |
| Document: 0001213900-26-075090.txt | 0001213900-26-075090 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 19d ago | 8-K | — | awaiting T+5 | — | — |
Jul 21, 2026 14w ago | 8-K | $0.2944 $0.2184 | ▼ −25.82% | ▼ −24.82% | — |
Jul 2, 2026 16w ago | 8-K | $0.2820 $0.2826 | ▼ −0.21% | ▲ +0.72% | — |
Apr 21, 2026 27w ago | 8-K | $0.4010 $0.4180 | ▲ +4.24% | ▲ +3.16% | — |
Apr 21, 2026 27w ago | Press Release | $0.4010 $0.4180 | ▲ +4.24% | ▲ +3.16% | — |
Apr 21, 2026 27w ago | EFFECT | $0.4010 $0.4180 | ▼ −4.24% | ▼ −3.16% | — |
Apr 17, 2026 27w ago | DEFA14A | $0.4900 $0.4100 | ▼ −16.33% | ▼ −17.24% | — |
Apr 17, 2026 27w ago | 8-K | $0.4900 $0.4100 | ▲ +16.33% | ▲ +17.24% | — |
Feb 26, 2026 34w ago | 8-K | $1.09 $0.8670 | ▼ −20.46% | ▼ −19.33% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers